3,5-di-tert-butylcatechol has been researched along with Muscle Contraction in 2 studies
*Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fusi, F; Höller, C; Kraft, B; Kress, HG; Lacava, C; Michalek-Sauberer, A; Sgaragli, G; Sipos, E; Weigl, LG | 1 |
| Ferrara, A; Fusi, F; Saponara, S; Sgaragli, G | 1 |
2 other study(ies) available for 3,5-di-tert-butylcatechol and Muscle Contraction
| Article | Year |
|---|---|
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Calcium Channel Agonists; Catechols; Cells, Cultured; Dose-Response Relationship, Drug; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction; Muscle Fibers, Skeletal; Predictive Value of Tests; Risk Assessment; Risk Factors; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Time Factors | 2012 |
Mechanisms of the antispasmodic activity of 3,5-di-t-butyl catechol (DTCAT) on rat vascular smooth muscles.
Topics: Animals; Aorta; Calcium; Calcium Channels; Catechols; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Rats; Rats, Sprague-Dawley; Ryanodine; Ryanodine Receptor Calcium Release Channel; Spasm | 2007 |